CY1115126T1 - METHOD AND VACCINE INCLUDING COPYRIGHT 1 FOR THE TREATMENT OF PSYCHIATRIC DISORDERS - Google Patents

METHOD AND VACCINE INCLUDING COPYRIGHT 1 FOR THE TREATMENT OF PSYCHIATRIC DISORDERS

Info

Publication number
CY1115126T1
CY1115126T1 CY20131101009T CY131101009T CY1115126T1 CY 1115126 T1 CY1115126 T1 CY 1115126T1 CY 20131101009 T CY20131101009 T CY 20131101009T CY 131101009 T CY131101009 T CY 131101009T CY 1115126 T1 CY1115126 T1 CY 1115126T1
Authority
CY
Cyprus
Prior art keywords
treatment
psychiatric disorders
vaccine including
including copyright
copolymer
Prior art date
Application number
CY20131101009T
Other languages
Greek (el)
Inventor
Michal Eisenbach-Schwartz
Jonathan Kipnis
Original Assignee
Yeda Research And Development Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04801601.8A external-priority patent/EP1701730B1/en
Application filed by Yeda Research And Development Co., Ltd. filed Critical Yeda Research And Development Co., Ltd.
Publication of CY1115126T1 publication Critical patent/CY1115126T1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Συμπολυμερές Ι, σχετικό με Συμπολυμερές Ι πεπτίδιο, σχετικό με Συμπολυμερές Ι πολυπεπτίδιο και Τ κύτταρα που ενεργοποιούνται με αυτά είναι χρήσιμα σε μεθόδους και συνθέσεις για θεραπεία ψυχιατρικών διαταραχών, ασθενειών και καταστάσεων.Copolymer I, Copolymer I related peptide, Copolymer I polypeptide and activated T cells are useful in methods and compositions for the treatment of psychiatric disorders, diseases and conditions.

CY20131101009T 2003-12-09 2013-11-14 METHOD AND VACCINE INCLUDING COPYRIGHT 1 FOR THE TREATMENT OF PSYCHIATRIC DISORDERS CY1115126T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52776303A 2003-12-09 2003-12-09
EP04801601.8A EP1701730B1 (en) 2003-12-09 2004-12-09 Method and vaccine comprising copolymer 1 for treatment of psychiatric disorders

Publications (1)

Publication Number Publication Date
CY1115126T1 true CY1115126T1 (en) 2016-12-14

Family

ID=58464017

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20131101009T CY1115126T1 (en) 2003-12-09 2013-11-14 METHOD AND VACCINE INCLUDING COPYRIGHT 1 FOR THE TREATMENT OF PSYCHIATRIC DISORDERS

Country Status (1)

Country Link
CY (1) CY1115126T1 (en)

Similar Documents

Publication Publication Date Title
CY1120070T1 (en) METHOD OF THERAPEUTIC TREATMENT WITH THE USE OF ANTI-ERBB-METHYSINEOID ANTIBODY conjugates
CY1119263T1 (en) COMPOSITIONS AND METHODS FOR BONE BALANCING INCREASE
CY1119106T1 (en) ANTIBODIES AGAINST MASP-2
CY1110225T1 (en) CIRCULAR PROJECTS OF PROTEIN Tyrosine kinase
CY1116385T1 (en) ANTIMONATIC CONFIGURATION OF EXPRESSION OF APLIPOPROTEIN B
CY1108074T1 (en) IMMUNOLOGICAL METHODS FOR REGULATING MYOSTATIN IN SCIENCE
CY1118171T1 (en) THERAPEUTIC TREATMENT OF BEN4
CY1115059T1 (en) THERAPEUTIC APPARATUS USEFUL IN THE THERAPEUTIC TREATMENT OF SUPPLEMENTARY DISORDERS
CY1108874T1 (en) USE OF IK-KINASE ANALYPES IN PAIN TREATMENT
DK1212422T3 (en) Human CTLA-4 antibodies and their uses
CY1110177T1 (en) Z-CARBONYLSYL SUBSTITUTED BISINSULARS AS RAF MOTION INHIBITORS
CY1108083T1 (en) NEISSERIA MENINGITIDIS ANTIGENS AND COMPOSITIONS
NO20061736L (en) Crystal form of epothilone B
CY1113312T1 (en) TYROSINE PROTEIN MOVEMENT CYCLE INPUTS
DK1409544T3 (en) Human DR4 antibodies and uses thereof
CY1113243T1 (en) METHODS OF TREATMENT USING CTLA-4
CY1112055T1 (en) COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF LUNG TUMOR
CY1105078T1 (en) COMPETITORS TECH
CY1113379T1 (en) KDR Peptides and Vaccines Included
CY1106133T1 (en) Agonists of corticotropin-releasing factor 2
DE602004017326D1 (en) TETRAHYDROCARBAZOL DERIVATIVES AND THEIR PHARMACEUTICAL USE
NO20011537L (en) Chemokine receptor peptide vaccines for the treatment and prevention of diabetes
NO20053903D0 (en) Nukleotidlipidesterderivater.
DK1290160T3 (en) Human Pellino polypeptides
NO20060781L (en) Use of soluble CD164 in inflammatory and / or autoimmune disorders